Outcomes of Switching from Aflibercept to Ranibizumab

By http://www.midatlanticretina.com/author
April 30, 2019

With age-related macular degeneration becoming a larger issue across the globe, more physicians are participating in research regarding its treatment options. Dr. Jason Hsu, and his colleagues at the Wills Eye Hospital presented a study at ARVO 2019 regarding short-term outcomes of patients, with nAMD, who switched from afliberecept to ranibizumab.

Watch the video to learn more.



Comments are closed.